Selected article for: "disease severity and intensive care"
Author: Wu, Beibei; Wang, Liyin; Jiang, Lili; Dong, Lili; Xu, Fengli; Lu, Yili; Jin, Jiahui; Wang, Zhanyue; Liang, Guang; Shan, Xiaoou
Title: n-butanol extract from Folium isatidis inhibits the lipopolysaccharide-induced downregulation of CXCR1 and CXCR2 on human neutrophils
  • Document date: 2017_10_25
    • ID: w85t4zz6_19
    Snippet: Sepsis remains a threat to human health, primarily due to a lack of effective therapies (3). With current treatment options, the mortality rate of patients with sepsis remains high at ~30%, and mortality rates increase directly with disease severity (24) . A previous worldwide survey of relevant pathogens in intensive care units found that the majority of patients with sepsis had blood cultures positive for Gram-negative bacteria (25) . LPS, a co.....
    Document: Sepsis remains a threat to human health, primarily due to a lack of effective therapies (3). With current treatment options, the mortality rate of patients with sepsis remains high at ~30%, and mortality rates increase directly with disease severity (24) . A previous worldwide survey of relevant pathogens in intensive care units found that the majority of patients with sepsis had blood cultures positive for Gram-negative bacteria (25) . LPS, a component of the outer leaflet of the outer membrane of Gram-negative bacteria, is a key molecule in the induction of sepsis. Therefore, the present study used LPS to simulate sepsis induced by Gram-negative bacteria infection.

    Search related documents:
    Co phrase search for related documents
    • blood culture and present study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • blood culture and sepsis patient: 1, 2, 3, 4
    • care unit and present study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • care unit and relevant pathogen: 1
    • care unit and sepsis patient: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
    • current treatment option and present study: 1
    • directly increase and present study: 1, 2, 3, 4
    • disease severity and present study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • disease severity and relevant pathogen: 1, 2, 3
    • disease severity and sepsis patient: 1, 2, 3, 4, 5, 6, 7
    • effective therapy and present study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • effective therapy and sepsis patient: 1
    • Gram negative bacteria and present study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • Gram negative bacteria and present study LPS: 1
    • Gram negative bacteria and sepsis patient: 1
    • Gram negative bacteria outer membrane and present study: 1
    • Gram negative bacteria outer membrane and present study LPS: 1
    • high remain and present study: 1, 2, 3, 4, 5, 6
    • human health and relevant pathogen: 1, 2, 3